Variant: 2-203515801-DEL

Allele Count: 709
Allele Number: 20914
Allele Frequency: 0.0339
SVTYPE: DEL
START: 203515801
END: 203521099
SVLEN: -5300
Number of Homozygotes: 36
Reference: T2T-CHM13

T2T-specific: not in

Browser:
Region annotation
RegionGene IDGene Detail
RefSeqintronicNBEAL1.

Allele frequency distribution
Linkage disequilibrium Plot

LD results for 2-203515801-DEL

The R2 statistic is the correlation coefficient of genotypes between pairs of loci. D' is the normalized LD statistic by dividing LD statistic D by its theoretical maximum, while D = pAB - pA * pB.

GWAS Catalog
LD SNPLD R2Risk AlleleGeneTrait ClassTraitOR/BetaP-valueStudyAncestry
2-203447953-T-AAFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs114123510-AWDR12Cardiovascular diseaseCoronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)1.133E-19GCST004787European, NR
2-203412714-T-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs114393235-GBiological processSmoking initiation0.01431E-30GCST90243985European, East Asian, Hispanic or Latin American, African unspecified
2-203292850-C-TAFR:0.22 AMR:0.96 EAS: EUR:1.00 SAS:0.93 10K:0.60rs115400054-CFAM117BLipid or lipoprotein measurementCholesterol, total0.0545E-9GCST002896European
2-203738256-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs115600411-?CYP20A1Cardiovascular diseaseNon-lobar intracerebral hemorrhage (MTAG)1.0989011E-6GCST008876European
2-203738256-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs115600411-GNRHematological measurementHemoglobin concentration5E-10GCST90002314African American or Afro-Caribbean, African unspecified, European, East Asian, Hispanic or Latin American, South Asian
2-203738256-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs115600411-CCYP20A1Other measurementPeriventricular white matter hyperintensities0.0487E-8GCST010726Hispanic or Latin American, European, African American or Afro-Caribbean
2-203738256-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs115600411-CNeurological disorderInsomnia0.0112E-10GCST90131903European
2-203738256-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs115600411-COther measurementRenin levels0.1362E-12GCST90249281European
2-203738256-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs115600411-?Other measurementT2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)5E-12GCST90320825European
2-203510795-C-AAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs115654617-ANBEAL1Cardiovascular diseaseCoronary artery disease0.11792E-32GCST005196NR
2-203698452-C-TAFR:0.93 AMR:0.92 EAS:1.00 EUR:0.97 SAS:1.00 10K:0.95rs116219813-TNRHematological measurementHemoglobin concentration0.0188031E-11GCST90002310European
2-203514744-A-GAFR:1.00 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.98rs140168762-?Cardiovascular diseaseMyocardial infarction0.90021E-19GCST90432175Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR
2-203412489-G-AAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs142250318-?Cardiovascular diseaseCoronary artery disease or fibrinogen levels (pleiotropy)5E-29GCST90129546European, South Asian, East Asian, European
2-203310657-A-CAFR: AMR:0.94 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.86rs143805266-?Cardiovascular diseaseMyocardial infarction0.90092E-19GCST90432175Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR
2-203267724-G-AAFR: AMR:0.88 EAS:1.00 EUR:0.98 SAS:0.93 10K:0.84rs143911965-ABiological processSmoking initiation0.01481E-32GCST90243985European, East Asian, Hispanic or Latin American, African unspecified
2-203509563-T-CAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs145538381-?NBEAL1Cardiovascular diseaseNon-lobar intracerebral hemorrhage (MTAG)1.11111122E-7GCST008876European
2-203343235-G-AAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs145664840-ANeurological disorderInsomnia0.0093E-11GCST90131901European
2-203568623-T-CAFR:0.91 AMR:0.90 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs147932234-?Cardiovascular diseaseCoronary heart disease1E-10GCST90446534European
2-203494025-C-TAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs148812085-TCardiovascular diseaseCoronary artery disease1.1215E-50GCST90132314European, NR
2-203393957-C-TAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs149163995-?ALS2CR8Cardiovascular diseaseMigraine1.08225114E-10GCST003986European
2-203449759-G-AAFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs149268645-GNRBiological processSuicide attempts in major depressive disorder or bipolar disorder or schizophrenia1.17647054E-7GCST008123European
2-203449759-G-AAFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs149268645-GNRBiological processSuicide attempts in major depressive disorder or bipolar disorder or schizophrenia1.17647054E-7GCST008123European
2-203333540-G-CAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs150622102-CNeurological disorderAlzheimer's disease3E-8GCST90301303European, African American or Afro-Caribbean, African unspecified, East Asian, Hispanic or Latin American
2-203521093-T-CAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs181256816-COther measurementVertex-wise cortical thickness8.877E-19GCST90095131European
2-203521093-T-CAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs181256816-CNROther measurementCortical surface area8E-15GCST90091060European
2-203521093-T-CAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs181256816-?Other measurementPersonality traits or cognitive traits (multivariate analysis)4E-9GCST90270074European
2-203521094-G-AAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs185726277-ANROther measurementCortical thickness1E-17GCST90091061European
2-203345718-C-TAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs186399184-?NROther measurementWhite matter microstructure (radial diusivities)8E-9GCST009540European
2-203345718-C-TAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs186399184-?NROther measurementWhite matter microstructure (radial diusivities)2E-12GCST009540European
2-203345718-C-TAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs186399184-?NROther measurementWhite matter microstructure (radial diusivities)1E-8GCST009540European
2-203345718-C-TAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs186399184-?NROther measurementWhite matter microstructure (radial diusivities)1E-8GCST009540European
2-203345718-C-TAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs186399184-?NROther measurementWhite matter microstructure (fractional anisotropy)7E-10GCST009539European
2-203345718-C-TAFR:0.33 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs186399184-?NROther measurementWhite matter microstructure (fractional anisotropy)4E-8GCST009539European
2-203679497-A-TAFR:0.93 AMR:0.90 EAS:1.00 EUR:0.91 SAS:0.63 10K:0.91rs188186531-ACardiovascular diseaseIschemic stroke (small-vessel)1.214E-7GCST005841East Asian, European, African American or Afro-Caribbean, South Asian, Asian unspecified, Hispanic or Latin American
2-203473762-T-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs188517380-TCardiovascular measurementPulse pressure0.027E-11GCST90301701European
2-203412444-A-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs191602009-?Cardiovascular diseaseMigraine (MTAG)0.0227E-9GCST90269766European
2-203412444-A-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs191602009-?Cardiovascular diseaseMigraine (MTAG)0.0227E-9GCST90269766European
2-203412444-A-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs191602009-?Cardiovascular diseaseSmall vessel stroke (MTAG)0.0258E-9GCST90103795European
2-203412444-A-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs191602009-?Cardiovascular diseaseSmall vessel stroke (MTAG)0.0258E-9GCST90103795European
2-203497785-C-TAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs2351524-?Cardiovascular diseaseCoronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy)2E-24GCST90129548European, South Asian, East Asian, European
2-203497785-C-TAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs2351524-?Cardiovascular diseaseCoronary artery disease or tissue plasminogen activator levels (pleiotropy)2E-24GCST90129547European, South Asian, East Asian, European
2-203497785-C-TAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs2351524-TNBEAL1Other measurementWhite matter hyperintensities6E-9GCST012580European, African American or Afro-Caribbean
2-203382498-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs35212307-?Cardiovascular diseaseCoronary artery disease5E-49GCST90132314European, NR
2-203382498-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs35212307-CWDR12Other measurementWhite matter hyperintensities4E-8GCST012580European, African American or Afro-Caribbean
2-203515877-A-GAFR:0.97 AMR:0.90 EAS:1.00 EUR:0.95 SAS:1.00 10K:0.95rs375380888-GOther traitHeadache or HbA1c levels0.976E-10GCST90281122European
2-203497627-A-GAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs4675310-AOther traitAngina pectoris0.0854E-9GCST90018793European, East Asian
2-203497627-A-GAFR:0.89 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.96rs4675310-AOther measurementExtensive basal ganglia perivascular space burden3E-9GCST90244153European
2-203369754-G-AAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs6435169-?Cardiovascular diseaseBody fat percentage or coronary artery disease (MTAG)0.13347E-10GCST90085924European, East Asian, South Asian, African American or Afro-Caribbean, European, East Asian, South Asian, African American or Afro-Caribbean, Hispanic or Latin American
2-203369754-G-AAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs6435169-?Cardiovascular diseaseBody fat percentage or coronary artery disease (MTAG)0.13347E-10GCST90085924European, East Asian, South Asian, African American or Afro-Caribbean, European, East Asian, South Asian, African American or Afro-Caribbean, Hispanic or Latin American
2-203278940-A-GAFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85rs6705330-GBiological processSmoking initiation0.01451E-31GCST90243985European, East Asian, Hispanic or Latin American, African unspecified
2-203362617-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs6725887-CWDR12Cardiovascular diseaseMyocardial infarction (early onset)1.171E-8GCST000340European
2-203362617-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs6725887-CWDR12Cardiovascular diseaseCoronary heart disease1.141E-9GCST000998European
2-203362617-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs6725887-CWDR12Cardiovascular diseaseCoronary artery disease1.142E-8GCST002289NR
2-203362617-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs6725887-CNRCardiovascular diseaseCoronary artery disease1.156E-8GCST011488South Asian, European
2-203490535-G-AAFR:0.28 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.89rs6728861-ANBEAL1Cardiovascular diseaseCoronary artery disease0.10541E-32GCST005195NR
2-203413541-C-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72926767-GCARFCardiovascular diseaseMyocardial infarction1.121E-21GCST011365European, NR, European, NR
2-203413541-C-GAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72926767-?Cardiovascular diseaseMyocardial infarction0.89987E-20GCST90432175Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR
2-203421000-C-TAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72926772-TCARFCardiovascular diseaseCoronary artery disease1.135E-18GCST010479East Asian, European, East Asian
2-203448861-A-GAFR: AMR:0.94 EAS: EUR:0.92 SAS:1.00 10K:0.56rs72928605-?FAM117B, ICA1L, WDR12, CARF, NBEAL1, CYP20A1, ABI2Other measurementBrain morphology (MOSTest)1E-8GCST010703European
2-203456367-T-AAFR:0.30 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72928613-?Cardiovascular diseaseHeadache or migraine5E-9GCST90267554European
2-203463563-A-TAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72932557-TCARFOther measurementWhite matter hyperintensities4E-8GCST012580European, African American or Afro-Caribbean
2-203266227-G-CAFR: AMR:0.88 EAS:0.94 EUR:0.98 SAS:0.93 10K:0.85rs72932727-GICA1LCardiovascular diseaseNon-lobar intracerebral hemorrhage (MTAG)1.11111122E-8GCST008876European
2-203266227-G-CAFR: AMR:0.88 EAS:0.94 EUR:0.98 SAS:0.93 10K:0.85rs72932727-?Neurological disorderAlzheimer’s disease polygenic risk score (upper quantile vs lower quantile)7E-15GCST90132260European
2-203277777-A-TAFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85rs72932741-TBiological processSmoking initiation0.01451E-31GCST90243985European, East Asian, Hispanic or Latin American, African unspecified
2-203533274-T-GAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs72934505-TNBEAL1Other measurementWhite matter hyperintensity burden6E-8GCST003013European, African American or Afro-Caribbean, South East Asian, Hispanic or Latin American, East Asian
2-203533274-T-GAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs72934505-TNBEAL1Other measurementWhite matter hyperintensity burden5E-8GCST003013European, African American or Afro-Caribbean, South East Asian, Hispanic or Latin American, East Asian
2-203533274-T-GAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs72934505-TICA1L, WDR12, CARF, NBEAL1, CYP20A1Other measurementWhite matter hyperintensities6.7934E-13GCST010101European, African unspecified, Hispanic or Latin American, Asian unspecified
2-203533274-T-GAFR:1.00 AMR:0.96 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.97rs72934505-?ICA1L, WDR12, CARF, NBEAL1, CYP20A1Other measurementWhite matter integrity (fractional anisotropy)7E-8GCST010102European
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-TNBEAL1Cardiovascular diseaseCoronary artery disease0.1282E-32GCST005194NR
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-TICA1L, WDR12, CARF, NBEAL1Cardiovascular diseaseLacunar stroke1.254E-9GCST90014122European
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-TWDR12, ICA1L, CARF, NBEAL1Cardiovascular diseaseLacunar stroke1.225E-8GCST90014123African American or Afro-Caribbean, European, Hispanic or Latin American
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-?Cardiovascular diseaseCoronary artery disease or von Willebrand factor levels (pleiotropy)4E-26GCST90129544European, South Asian, East Asian, European, African American or Afro-Caribbean, Hispanic or Latin American
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-?Cardiovascular diseaseCoronary artery disease or factor VII levels (pleiotropy)5E-26GCST90129542European, South Asian, East Asian, European, African American or Afro-Caribbean
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-?Cardiovascular diseaseCoronary artery disease or factor VIII levels (pleiotropy)4E-26GCST90129543European, South Asian, East Asian, European, African American or Afro-Caribbean, East Asian, South Asian, Hispanic or Latin American
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-?Cardiovascular diseaseCoronary artery disease or factor XI levels (pleiotropy)5E-26GCST90129545European, South Asian, East Asian, European
2-203585748-T-CAFR: AMR:0.72 EAS: EUR:0.86 SAS: 10K:0.49rs72934535-CCardiovascular diseaseIschemic heart disease (PheCode 411)7E-9GCST008370European
2-203607571-T-GAFR: AMR:0.86 EAS: EUR:0.93 SAS:1.00 10K:0.54rs72934556-GOther measurementIDP dMRI TBSS L2 Anterior limb of internal capsule R0.111E-13GCST90004139European
2-203621853-A-GAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934573-GCardiovascular diseaseMyocardial infarction0.13517E-15GCST90018877European, East Asian
2-203625846-T-GAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934583-TNBEAL1Other measurementPeriventricular white matter hyperintensities0.05291E-9GCST010726Hispanic or Latin American, European, African American or Afro-Caribbean
2-203625846-T-GAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934583-TNBEAL1Other measurementWhite matter hyperintensity volume (adjusted for hypertension)0.06271E-12GCST011949African American or Afro-Caribbean, African American or Afro-Caribbean, European
2-203625846-T-GAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934583-TNBEAL1Cardiovascular diseaseWhite matter hyperintensity volume x hypertension interaction (2df)5E-12GCST011952European, African American or Afro-Caribbean
2-203625846-T-GAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934583-TNBEAL1Other measurementWhite matter hyperintensity volume0.06277E-13GCST011946African American or Afro-Caribbean, European
2-203634725-C-TAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934589-?NBEAL1Cardiovascular diseaseNon-lobar intracerebral hemorrhage (MTAG)1.11111122E-7GCST008876European
2-203634725-C-TAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934589-CCardiovascular diseaseSmall vessel stroke1.167E-7GCST90104543European
2-203634725-C-TAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934589-CCardiovascular diseaseSmall vessel stroke (MTAG)1.192E-14GCST90162546European
2-203636552-G-AAFR:1.00 AMR:0.92 EAS:1.00 EUR:0.99 SAS:1.00 10K:0.97rs72934591-?Cardiovascular diseaseMyocardial infarction0.90143E-19GCST90432175Greater Middle Eastern (Middle Eastern, North African or Persian), European, NR
2-203647911-G-AAFR:0.97 AMR:0.92 EAS:1.00 EUR:0.97 SAS:1.00 10K:0.96rs72934601-?Other measurementBrain morphology (MOSTest)1E-14GCST90239729European
2-203372482-G-AAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72934760-AintergenicOther measurementPeriventricular white matter hyperintensities0.0542E-9GCST010726Hispanic or Latin American, European, African American or Afro-Caribbean
2-203653132-T-GAFR:0.97 AMR:0.92 EAS:1.00 EUR:0.97 SAS:1.00 10K:0.96rs72936304-TOther measurementRenin levels0.08213E-10GCST90012038European
2-203405678-T-CAFR:0.33 AMR:1.00 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs72936869-?ALS2CR8Cardiovascular diseaseNon-lobar intracerebral hemorrhage (MTAG)1.11111121E-7GCST008876European
2-203738174-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs72938315-?Other diseaseRespiratory diseases2E-8GCST007076European
2-203738174-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs72938315-CCYP20A1Other measurementAppendicular lean mass0.02077E-15GCST90000025European
2-203738174-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs72938315-GNRLipid or lipoprotein measurementApolipoprotein B levels0.02632E-14GCST90019496European, African unspecified, South Asian
2-203738174-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs72938315-GNRLipid or lipoprotein measurementTotal cholesterol levels0.0272E-15GCST90019501European, African unspecified, South Asian
2-203738174-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs72938315-GNRLiver enzyme measurementSerum alkaline phosphatase levels0.03054E-19GCST90019494European, African unspecified, South Asian
2-203738174-C-GAFR:0.90 AMR:0.84 EAS:1.00 EUR:0.93 SAS:1.00 10K:0.91rs72938315-GNRLipid or lipoprotein measurementLow density lipoprotein cholesterol levels0.02541E-13GCST90019512European, African unspecified, South Asian
2-203289818-G-AAFR: AMR:0.94 EAS:1.00 EUR:1.00 SAS:0.93 10K:0.86rs74675536-?NROther measurementWhite matter microstructure (mean diusivities)2E-11GCST009538European
2-203289818-G-AAFR: AMR:0.94 EAS:1.00 EUR:1.00 SAS:0.93 10K:0.86rs74675536-?NROther measurementWhite matter microstructure (mean diusivities)5E-8GCST009538European
2-203369810-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs7582720-?WDR12Cardiovascular diseaseCoronary artery disease or ischemic stroke4E-9GCST002287NR
2-203369810-T-CAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs7582720-?WDR12Cardiovascular diseaseCoronary artery disease or large artery stroke3E-8GCST002290NR
2-203397246-A-GAFR:0.33 AMR:0.98 EAS:1.00 EUR:1.00 SAS:1.00 10K:0.90rs7603972-ACARF1Other measurementWhite matter hyperintensity volume0.072E-13GCST011947European
2-203281673-C-GAFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85rs76122535-GICA1L, WDR12, CARF, NBEAL1Other measurementWhite matter integrity (fractional anisotropy)0.3609126E-9GCST010102European
2-203281673-C-GAFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85rs76122535-GOther measurementWhite matter fractional anisotropy x age interaction (2df)4E-12GCST90100584European
2-203280719-C-TAFR: AMR:0.88 EAS:1.00 EUR:0.99 SAS:0.93 10K:0.85rs78128841-TBiological processSmoking initiation0.01451E-31GCST90243985European, East Asian, Hispanic or Latin American, African unspecified
Epigenetic markers
MarkerCell typeRange
H3K27ac22Rv1203517452_203517841
H3K27acRWPE2203519522_203521755
H3K27acRWPE1203520112_203521347
H3K27acVCaP203517056_203518549
H3K27acepithelial_cell_of_prostate_male203519519_203521634;203517565_203517987
H3K36me3MG63203520308_203521397
H3K36me3SJCRH30203519789_203520656
H3K4me1Caco-2203521018_203523964;203519970_203520405
H3K4me1HAP-1203517627_203518686
Fixation index Fst
The Fixation index Fst was adopted as the measure for assessing population differences.